Login / Signup

Outcomes of multiple myeloma patients with del 17p undergoing autologous stem cell transplantation.

Iuliana VaxmanAlissa VisramPrashant KapoorShaji KumarAngela DispenzieriFrancis BuadiDavid DingliEli MuchtarWilson I GonsalvesSundararajan Vincent RajkumarTaxiarchis V KourelisRahma M WarsameMartha LacyMorie A Gertz
Published in: American journal of hematology (2020)
Keyphrases
  • stem cell transplantation
  • multiple myeloma
  • high dose
  • bone marrow
  • cell therapy
  • platelet rich plasma
  • type diabetes
  • metabolic syndrome
  • skeletal muscle
  • insulin resistance